Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $9.93 in the prior trading day, Olema Pharmaceuticals Inc (NASDAQ: OLMA) closed at $9.87, down -0.60%. In other words, the price has decreased by $-0.60 from its previous closing price. On the day, 0.68 million shares were traded. OLMA stock price reached its highest trading level at $10.14 during the session, while it also had its lowest trading level at $9.76.
Ratios:
Our goal is to gain a better understanding of OLMA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.33 and its Current Ratio is at 12.33. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 30, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $20.
On July 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $21.Oppenheimer initiated its Outperform rating on July 21, 2023, with a $21 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 28 ’24 when Harmon Cyrus sold 20,000 shares for $10.97 per share. The transaction valued at 219,400 led to the insider holds 826,283 shares of the business.
Harmon Cyrus sold 25,000 shares of OLMA for $310,309 on Feb 29 ’24. The Director now owns 846,283 shares after completing the transaction at $12.41 per share. On Feb 01 ’24, another insider, Harmon Cyrus, who serves as the Director of the company, sold 5,000 shares for $15.56 each. As a result, the insider received 77,800 and left with 871,283 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OLMA now has a Market Capitalization of 551878080 and an Enterprise Value of 295843392.
Stock Price History:
Over the past 52 weeks, OLMA has reached a high of $17.79, while it has fallen to a 52-week low of $3.85. The 50-Day Moving Average of the stock is -21.01%, while the 200-Day Moving Average is calculated to be -18.44%.
Shares Statistics:
The stock has traded on average 820.16K shares per day over the past 3-months and 656290 shares per day over the last 10 days, according to various share statistics. A total of 54.99M shares are outstanding, with a floating share count of 48.58M. Insiders hold about 13.13% of the company’s shares, while institutions hold 86.73% stake in the company. Shares short for OLMA as of 1711584000 were 8103322 with a Short Ratio of 9.88, compared to 1709164800 on 4868837. Therefore, it implies a Short% of Shares Outstanding of 8103322 and a Short% of Float of 19.399999.
Earnings Estimates
Olema Pharmaceuticals Inc (OLMA) is presently subject to a detailed evaluation by Loma Negra Compania Industrial analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $20.56, with high estimates of $7.09 and low estimates of $9.87.
